PharmaLogic Executive and Leadership Team

Etienne Montagut, the President & Chief Executive Officer at PharmaLogic, directs the overarching corporate strategy and operational execution for the global contract development and manufacturing organization (CDMO). Montagut guides the company's expansion in diagnostic and therapeutic radiopharmaceuticals, leveraging a network of radiopharmacies and manufacturing facilities across North America and Europe. This leadership role involves setting the vision for developing, manufacturing, and distributing clinical and commercial radiopharmaceutical products to pharmaceutical partners and healthcare providers. Etienne Montagut ensures alignment with market demands and regulatory landscapes, driving innovation in radiopharmaceutical science and delivery. The Chief Executive Officer's focus remains on enhancing PharmaLogic's position as a premier CDMO, fostering strategic partnerships, and achieving sustainable growth within the specialized radiopharmaceutical sector.

Mark Dmytruk, the Chief Financial Officer at PharmaLogic, directs all financial planning, management, and reporting activities for the global contract development and manufacturing organization. Dmytruk manages fiscal operations, including budgeting, forecasting, and capital allocation, ensuring the financial health and strategic growth of the company. This executive role involves overseeing financial strategies related to the development, manufacturing, and distribution of radiopharmaceutical products across North America and Europe. The Chief Financial Officer's purview includes managing investor relations, securing funding for expansion initiatives, and ensuring compliance with all financial regulations. Mark Dmytruk provides critical financial insights to support executive decision-making, driving profitability and long-term value for PharmaLogic's stakeholders.

Glen Palmer, the Chief Operating Officer at PharmaLogic, oversees the day-to-day operational activities critical to the company's contract development and manufacturing operations. Palmer manages the extensive network of radiopharmacies and manufacturing facilities situated across North America and Europe, ensuring efficient production and distribution of radiopharmaceutical products. This executive function involves optimizing supply chain logistics and manufacturing processes to meet the stringent demands of clinical and commercial distribution. The Chief Operating Officer's responsibilities extend to maintaining high standards of quality and compliance across all operational sites, directly supporting pharmaceutical partners and healthcare providers. Glen Palmer drives operational excellence, focusing on scalability and reliability to enhance PharmaLogic's capacity for delivering specialized radiopharmaceutical solutions.

Timothy Quinton, the President at PharmaLogic, drives commercial strategy and market expansion for the global contract development and manufacturing organization. Quinton focuses on strengthening relationships with pharmaceutical partners and healthcare providers, ensuring the effective distribution of diagnostic and therapeutic radiopharmaceuticals across North America and Europe. This leadership position involves overseeing sales, marketing, and business development efforts, aligning them with the company's manufacturing and development capabilities. The President's responsibilities include identifying new market opportunities and enhancing the company's service offerings in radiopharmaceutical production. Timothy Quinton plays a pivotal role in advancing PharmaLogic's commercial objectives and solidifying its market presence within the specialized radiopharmaceutical sector.

Pamela Wong, the Chief Legal Officer at PharmaLogic, provides comprehensive legal counsel and oversees all legal affairs for the global contract development and manufacturing organization. Wong manages corporate governance, regulatory compliance, and intellectual property matters, safeguarding the company's interests across its North American and European operations. This executive position involves advising on contracts with pharmaceutical partners and healthcare providers, ensuring adherence to industry-specific regulations governing radiopharmaceutical development and manufacturing. The Chief Legal Officer's responsibilities include managing litigation risks and developing legal strategies to support business objectives. Pamela Wong ensures that PharmaLogic operates within all legal frameworks, facilitating secure and compliant business practices.

Hallie Pierson, the Chief People Officer at PharmaLogic, leads all human resources functions and talent management strategies for the global contract development and manufacturing organization. Pierson oversees workforce planning, employee relations, compensation, and benefits programs, fostering a positive and productive work environment across North America and Europe. This executive role focuses on attracting, developing, and retaining top talent essential for the specialized fields of radiopharmaceutical development and manufacturing. The Chief People Officer's strategic initiatives support the company's mission by ensuring a skilled and engaged workforce capable of meeting the complex demands of pharmaceutical partners and healthcare providers. Hallie Pierson drives initiatives that enhance organizational culture and employee engagement, aligning human capital with PharmaLogic's growth objectives.